These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
651 related articles for article (PubMed ID: 21140330)
21. Current status of hepatitis C virus infection in Korea. Suh DJ; Jeong SH Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792 [TBL] [Abstract][Full Text] [Related]
22. Predicted effects of treatment for HCV infection vary among European countries. Deuffic-Burban S; Deltenre P; Buti M; Stroffolini T; Parkes J; Mühlberger N; Siebert U; Moreno C; Hatzakis A; Rosenberg W; Zeuzem S; Mathurin P Gastroenterology; 2012 Oct; 143(4):974-85.e14. PubMed ID: 22863764 [TBL] [Abstract][Full Text] [Related]
23. Ribavirin in the treatment of hepatitis C. Abonyi ME; Lakatos PL Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084 [TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C. Scherzer TM; Reddy KR; Wrba F; Hofer H; Staufer K; Steindl-Munda P; Gangl A; Ferenci P J Viral Hepat; 2008 Sep; 15(9):659-65. PubMed ID: 18637075 [TBL] [Abstract][Full Text] [Related]
25. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection. Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519 [TBL] [Abstract][Full Text] [Related]
26. Approach to the treatment-naïve patient with HCV genotype 1 infection. Muir AJ Infect Dis Clin North Am; 2012 Dec; 26(4):893-901. PubMed ID: 23083822 [TBL] [Abstract][Full Text] [Related]
27. Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more. Pearlman BL; Traub N Clin Infect Dis; 2011 Apr; 52(7):889-900. PubMed ID: 21427396 [TBL] [Abstract][Full Text] [Related]
28. HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection. Hsu SJ; Hsu CS; Liu CH; Liu CJ; Chen CL; Chen PJ; Chen DS; Kao JH Antivir Ther; 2011; 16(2):227-35. PubMed ID: 21447872 [TBL] [Abstract][Full Text] [Related]
29. Chronic hepatitis C virus infection: genotyping and its clinical role. Bowden DS; Berzsenyi MD Future Microbiol; 2006 Jun; 1(1):103-12. PubMed ID: 17661689 [TBL] [Abstract][Full Text] [Related]
30. Preparing the patient for success: treat or wait? Buti M; Esteban R Dig Liver Dis; 2013 Sep; 45 Suppl 5():S332-6. PubMed ID: 24091112 [TBL] [Abstract][Full Text] [Related]
31. [Chronic hepatitis C infection--eradication of the virus]. Ben Ari Z Harefuah; 2014 Jul; 153(7):392-3, 433. PubMed ID: 25189028 [TBL] [Abstract][Full Text] [Related]
32. Outcome of antiviral therapy in Egyptian Hepatitis C Virus (HCV) genotype 4 patients with advanced liver fibrosis. el-Khattib AA; Abdelhakam SM; Ghoraba DM; Ibrahim WA; Sayed MM Eur J Intern Med; 2012 Jan; 23(1):e34-5. PubMed ID: 22153547 [No Abstract] [Full Text] [Related]
33. Management of hepatitis C virus infection in childhood. Galoppo M; Galoppo C Ann Hepatol; 2010; 9 Suppl():98-102. PubMed ID: 20714004 [TBL] [Abstract][Full Text] [Related]
35. Antiviral activity of the new DAAs for the treatment of hepatitis C virus infection: virology and resistance. Chevaliez S Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S46-51. PubMed ID: 22248694 [TBL] [Abstract][Full Text] [Related]
36. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Villa E; Karampatou A; Cammà C; Di Leo A; Luongo M; Ferrari A; Petta S; Losi L; Taliani G; Trande P; Lei B; Graziosi A; Bernabucci V; Critelli R; Pazienza P; Rendina M; Antonelli A; Francavilla A Gastroenterology; 2011 Mar; 140(3):818-29. PubMed ID: 21167831 [TBL] [Abstract][Full Text] [Related]
37. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Crockett SD; Keeffe EB Ann Clin Microbiol Antimicrob; 2005 Sep; 4():13. PubMed ID: 16159399 [TBL] [Abstract][Full Text] [Related]
38. [Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Sarrazin C; Berg T; Cornberg M; Dollinger M; Ferenci P; Hinrichsen H; Klinker H; Kraus M; Manns M; Mauss S; Peck-Radosavljevic M; Schmidt H; Spengler U; Wedemeyer H; Wirth S; Zeuzem S Z Gastroenterol; 2012 Jan; 50(1):57-72. PubMed ID: 22222799 [TBL] [Abstract][Full Text] [Related]
39. Natural history of chronic hepatitis C: genotype 1 versus genotype 6. Seto WK; Lai CL; Fung J; Hung I; Yuen J; Young J; Wong DK; Yuen MF J Hepatol; 2010 Sep; 53(3):444-8. PubMed ID: 20554340 [TBL] [Abstract][Full Text] [Related]
40. Impact of HCV genetic differences on pathobiology of disease. Ripoli M; Pazienza V Expert Rev Anti Infect Ther; 2011 Sep; 9(9):747-59. PubMed ID: 21905784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]